Adjuvant trastuzumab in HER2-positive breast cancer.
Trastuzumab improves survival in the adjuvant treatment of HER-positive breast cancer, although combined therapy with anthracycline-based regimens has been associated with cardiac toxicity. We wanted to evaluate the efficacy and safety of a new nonanthracycline regimen with trastuzumab. We randomly...
| Main Authors: | Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, Arlene, Pawlicki, M., Pinter, T., Valero, V., Liu, M., Sauter, G., von Minckwitz, G., Visco, F., Bee, V., Buyse, M., Bendahmane, B., Tabah-Fisch, I., Lindsay, M., Riva, A., Crown, J., Breast, C. |
|---|---|
| Format: | Journal Article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/38973 |
Similar Items
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study
by: Au, H., et al.
Published: (2013)
by: Au, H., et al.
Published: (2013)
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011)
by: Eiermann, W., et al.
Published: (2011)
Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)
by: Chan, Arlene, et al.
Published: (2016)
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
by: Mackey, J., et al.
Published: (2016)
by: Mackey, J., et al.
Published: (2016)
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)
by: Chan, Arlene
Published: (2017)
Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)
by: Chan, Arlene, et al.
Published: (2012)
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
by: Chan, Arlene, et al.
Published: (2016)
by: Chan, Arlene, et al.
Published: (2016)
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
by: Martin, M., et al.
Published: (2017)
by: Martin, M., et al.
Published: (2017)
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2013)
by: Chan, Arlene, et al.
Published: (2013)
AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
by: Gianni, L., et al.
Published: (2013)
by: Gianni, L., et al.
Published: (2013)
Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]
by: Hasbullah, Harissa H, et al.
Published: (2018)
by: Hasbullah, Harissa H, et al.
Published: (2018)
Multifunctional Poly(D,L-Lactide-co-Glycolide)/ Montmorillonite (PLGA/MMT) Nanoparticles Decorated by Trastuzumab for Targeted Chemotherapy of Breast Cancer
by: Ranganathan, Balu, et al.
Published: (2014)
by: Ranganathan, Balu, et al.
Published: (2014)
Knowledge and related themes in Academic research
by: Bendahmane, Omayma
Published: (2013)
by: Bendahmane, Omayma
Published: (2013)
Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer
by: Chan, Arlene, et al.
Published: (2014)
by: Chan, Arlene, et al.
Published: (2014)
Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)
by: Chan, Arlene, et al.
Published: (2009)
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)
by: Cameron, David, et al.
Published: (2013)
Exploring the effectiveness of using big books in teaching primary English in Malaysian classrooms
by: Yaacob, Aizan, et al.
Published: (2008)
by: Yaacob, Aizan, et al.
Published: (2008)
Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy
by: Chan, Arlene, et al.
Published: (2013)
by: Chan, Arlene, et al.
Published: (2013)
Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
by: Chan, Arlene, et al.
Published: (2014)
by: Chan, Arlene, et al.
Published: (2014)
Glycolytic control of adjuvant-induced macrophage survival: Role of PI3K, MEK1/2, and Bcl-2
by: Chang, M., et al.
Published: (2009)
by: Chang, M., et al.
Published: (2009)
Wireless system identification for linear network
by: V.S., Asirvadam, et al.
Published: (2009)
by: V.S., Asirvadam, et al.
Published: (2009)
Kinematic contact-impact algorithm with friction
by: Wong, S.V., et al.
Published: (2001)
by: Wong, S.V., et al.
Published: (2001)
Melatonin modifies basal and stimulated insulin secretion via NADPH oxidase
by: Simões, D., et al.
Published: (2016)
by: Simões, D., et al.
Published: (2016)
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix
by: Rahman, Cheryl V., et al.
Published: (2013)
by: Rahman, Cheryl V., et al.
Published: (2013)
Time domain hydrodynamic analysis of Semi-submersible platforms
by: Yassir, M.E.A., et al.
Published: (2009)
by: Yassir, M.E.A., et al.
Published: (2009)
Use of statistical modelling to investigate the pathogenesis of claw horn disruption lesions in dairy cattle
by: Randall, L.V., et al.
Published: (2018)
by: Randall, L.V., et al.
Published: (2018)
Reporting of myelotoxicity associated wtih emerging regimems for the treatment of selected solid tumors
by: Chan, Arlene, et al.
Published: (2012)
by: Chan, Arlene, et al.
Published: (2012)
Effects Of Adjuvant Honey Therapy On Disease Activity, Lymphocyte Function And Lymphocyte Subsets In Patients With Systemic Lupus Erythematosus
by: Mohamad, Wathik M.
Published: (2009)
by: Mohamad, Wathik M.
Published: (2009)
People with an intellectual disability in the discourse of chronic and complex conditions: an invisible group?
by: Goddard, L., et al.
Published: (2008)
by: Goddard, L., et al.
Published: (2008)
Factors influencing success rate of ceramic veneers on endodontically treated anterior teeth: A systematic review
by: Lin, J., et al.
Published: (2023)
by: Lin, J., et al.
Published: (2023)
Theory, empiricism and practice: Commentary on TBLT in ARAL 2016
by: Bygate, M., et al.
Published: (2017)
by: Bygate, M., et al.
Published: (2017)
Estimating Peak Work Rate during Incremental Cycle Ergometry from the 6-minute Walk Distance: Differences between Reference Equations
by: Holland, A, et al.
Published: (2011)
by: Holland, A, et al.
Published: (2011)
Effect of delivery method on the efficacy of Salmonella vaccination in chickens
by: Atterbury, Robert J., et al.
Published: (2010)
by: Atterbury, Robert J., et al.
Published: (2010)
Stochastic resin transfer molding process
by: Park, M., et al.
Published: (2017)
by: Park, M., et al.
Published: (2017)
DUCTILITY OF HIGH PERFORMANCE CONCRETE
BEAMS USING SANDSTONE AGGREGATES
by: Kumar, P.S, et al.
Published: (2006)
by: Kumar, P.S, et al.
Published: (2006)
High Performance Reinforced Concrete Beams Made with Sandstone Reactive Aggregate
by: Kumar , P.S., et al.
Published: (2008)
by: Kumar , P.S., et al.
Published: (2008)
Provenance record from Mesoproterozoic-Cambrian sediments of Peary Land, North Greenland: Implications for the ice-covered Greenland Shield and Laurentian palaeogeography
by: Kirkland, Chris, et al.
Published: (2009)
by: Kirkland, Chris, et al.
Published: (2009)
Transition from island-arc to passive setting on the continental margin of Gondwana: U–Pb zircon dating of Neoproterozoic metaconglomerates from the SE margin of the Teplá–Barrandian Unit, Bohemian Massif
by: Sláma, J., et al.
Published: (2008)
by: Sláma, J., et al.
Published: (2008)
Heat treatment of cold-sprayed C355 Al for repair: microstructure and mechanical properties
by: Murray, J.W., et al.
Published: (2017)
by: Murray, J.W., et al.
Published: (2017)
A Predictive Model to Differentiate the Fruit Bats Cynopterus brachyotis and C. cf. brachyotis Forest (Chiroptera: Pteropodidae) from Malaysia Using Multivariate Analysis
by: Jayaraj, V.K., et al.
Published: (2012)
by: Jayaraj, V.K., et al.
Published: (2012)
Similar Items
-
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study
by: Au, H., et al.
Published: (2013) -
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011) -
Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016) -
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
by: Mackey, J., et al.
Published: (2016) -
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)